BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 17136864)

  • 1. Pharmacologic therapy for the cancer anorexia/weight loss syndrome: A data-driven, practical approach.
    Jatoi A
    J Support Oncol; 2006; 4(10):499-502. PubMed ID: 17136864
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Recent development in research and management of cancer anorexia-cachexia syndrome].
    Inui A
    Gan To Kagaku Ryoho; 2005 Jun; 32(6):743-9. PubMed ID: 15984510
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Feeding-related disorders in medicine, with special reference to cancer anorexia-cachexia syndrome].
    Inui A
    Rinsho Byori; 2006 Oct; 54(10):1044-51. PubMed ID: 17133993
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The management of anorexia by patients with advanced cancer: a critical review of the literature.
    Shragge JE; Wismer WV; Olson KL; Baracos VE
    Palliat Med; 2006 Sep; 20(6):623-9. PubMed ID: 17060256
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of megestrol acetate on anorexia, weight loss and cachexia in cancer and AIDS patients (review).
    Strang P
    Anticancer Res; 1997; 17(1B):657-62. PubMed ID: 9066597
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current management of cancer-associated anorexia and weight loss.
    Jatoi A; Loprinzi CL
    Oncology (Williston Park); 2001 Apr; 15(4):497-502, 508; discussion 508-10. PubMed ID: 11346935
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A placebo-controlled double blind trial of etanercept for the cancer anorexia/weight loss syndrome: results from N00C1 from the North Central Cancer Treatment Group.
    Jatoi A; Dakhil SR; Nguyen PL; Sloan JA; Kugler JW; Rowland KM; Soori GS; Wender DB; Fitch TR; Novotny PJ; Loprinzi CL
    Cancer; 2007 Sep; 110(6):1396-403. PubMed ID: 17674351
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological options for advanced cancer patients with loss of appetite and weight.
    Behl D; Jatoi A
    Expert Opin Pharmacother; 2007 Jun; 8(8):1085-90. PubMed ID: 17516872
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Palliative treatment of cancer anorexia with oral suspension of megestrol acetate.
    Tomíska M; Tomisková M; Salajka F; Adam Z; Vorlícek J
    Neoplasma; 2003; 50(3):227-33. PubMed ID: 12937858
    [TBL] [Abstract][Full Text] [Related]  

  • 10. On appetite and its loss.
    Jatoi A; Kumar S; Sloan JA; Nguyen PL
    J Clin Oncol; 2003 May; 21(9 Suppl):79s-81s. PubMed ID: 12743203
    [No Abstract]   [Full Text] [Related]  

  • 11. Involuntary weight loss in patients with advanced cancer: treatment is of modest benefit.
    J Support Oncol; 2006 Feb; 4(2):92. PubMed ID: 16499134
    [No Abstract]   [Full Text] [Related]  

  • 12. Megestrol acetate for the palliation of anorexia in advanced, incurable cancer patients.
    Mateen F; Jatoi A
    Clin Nutr; 2006 Oct; 25(5):711-5. PubMed ID: 16867306
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Functional Assessment of Anorexia/Cachexia Therapy (FAACT) Appetite Scale in veteran cancer patients.
    Chang VT; Xia Q; Kasimis B
    J Support Oncol; 2005; 3(5):377-82. PubMed ID: 16218262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nutritional support for malnourished patients with cancer.
    Baldwin C
    Curr Opin Support Palliat Care; 2011 Mar; 5(1):29-36. PubMed ID: 21326001
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The cancer cachexia syndrome.
    Puccio M; Nathanson L
    Semin Oncol; 1997 Jun; 24(3):277-87. PubMed ID: 9208884
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Review article: anorexia and cachexia in gastrointestinal cancer.
    Ockenga J; Valentini L
    Aliment Pharmacol Ther; 2005 Oct; 22(7):583-94. PubMed ID: 16181298
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hazards of quality-of-life data for clinical decision making.
    Somerfield M
    J Clin Oncol; 2003 May; 21(9 Suppl):82s-83s; discussion 83s. PubMed ID: 12743204
    [No Abstract]   [Full Text] [Related]  

  • 18. Pharmacologic management of anorexia/cachexia.
    Ottery FD; Walsh D; Strawford A
    Semin Oncol; 1998 Apr; 25(2 Suppl 6):35-44. PubMed ID: 9625382
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Medroxyprogesterone and palliative care: new indication. No impact on quality of life.
    Prescrire Int; 2001 Feb; 10(51):3-4. PubMed ID: 11503858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nutrition in the last days of life.
    Löbbe VA
    Curr Opin Support Palliat Care; 2009 Sep; 3(3):195-202. PubMed ID: 19528802
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.